110143-57-2 Usage
Uses
Used in Pharmaceutical Industry:
(2S,6R)-6-[[1(S)-Ethoxycarbonyl-3-phenylpropyl]amino]-5-oxo-(2-thienyl)perhydro-1,4-thiazepine is used as a potential pharmaceutical candidate for drug development due to its unique molecular structure and functional groups. Its specific properties and interactions with biological systems may contribute to the discovery of new therapeutic agents.
Used in Research Applications:
In the field of chemical research, (2S,6R)-6-[[1(S)-Ethoxycarbonyl-3-phenylpropyl]amino]-5-oxo-(2-thienyl)perhydro-1,4-thiazepine serves as a valuable compound for studying the effects of its structural components on various chemical and biological processes. Its unique features may provide insights into the development of new synthetic methods, reaction mechanisms, and potential applications in other industries.
Check Digit Verification of cas no
The CAS Registry Mumber 110143-57-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,0,1,4 and 3 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 110143-57:
(8*1)+(7*1)+(6*0)+(5*1)+(4*4)+(3*3)+(2*5)+(1*7)=62
62 % 10 = 2
So 110143-57-2 is a valid CAS Registry Number.
InChI:InChI=1/C21H26N2O3S2/c1-2-26-21(25)16(11-10-15-7-4-3-5-8-15)23-17-14-28-19(13-22-20(17)24)18-9-6-12-27-18/h3-9,12,16-17,19,23H,2,10-11,13-14H2,1H3,(H,22,24)/t16-,17-,19-/m0/s1
110143-57-2Relevant academic research and scientific papers
Angiotensin-Converting Enzyme Inhibitors: Perhydro-1,4-thiazepin-5-one Derivatives
Yanagisawa, Hiroaki,Ishihara, Sadao,Ando, Akiko,Kanazaki, Takuro,Miyamoto, Shuichi,et al.
, p. 1984 - 1991 (2007/10/02)
α-amino>-5-oxoperhydro-1,4-thiazepin-4-yl>acetic acids (monoester monoacids) and their dicarboxylic acids having the hydrophobic substituents at the 2- or 3-position of the thiazepinone ring were prepared and assayed for angiotensin-converting enzyme (ACE) inhibitory activity.The dicarboxylic acids having the pseudoequatorial amino groups at the 6-position and the pseudoequatorial hydrophobic substituents at the 2- or 3-position of the chair conformation of the thiazepinone ring had potent in vitro inhibitory activity.The monoester monoacids having the hydrophobic substituents at the 2-position suppressed pressor response to angiotensin I for a longer duration than those having the substituents at the 3-position when administered orally.The structure-activity relationship was studied by conformational energy calculations of the thiazepinone ring.